Cargando…
Increasing evidence for omalizumab in the treatment of bullous pemphigoid
Autores principales: | Lonowski, Sarah, Sachsman, Suzanne, Patel, Nirali, Truong, Allison, Holland, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044652/ https://www.ncbi.nlm.nih.gov/pubmed/32140524 http://dx.doi.org/10.1016/j.jdcr.2020.01.002 |
Ejemplares similares
-
Omalizumab as a corticosteroid‐sparing agent in the treatment of bullous pemphigoid
por: Vassallo, Camilla, et al.
Publicado: (2022) -
Bullous eczema presenting as bullous pemphigoid-like eruption: A case series
por: Atteh, George, et al.
Publicado: (2021) -
Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments
por: Bilgiç Temel, Aslı, et al.
Publicado: (2017) -
Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports
por: Thomsen, Kenneth, et al.
Publicado: (2018) -
Bullous Pemphigoid Associated with Multiple System Atrophy: Case Series
por: Snedden, Andrew, et al.
Publicado: (2021)